California State Teachers Retirement System (CalSTRS)
URGN icon

California State Teachers Retirement System (CalSTRS)’s UroGen Pharma URGN Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
44,949
+6,199
+16% +$168K ﹤0.01% 1686
2026
Q1 		$697K Buy
38,750
+36,478
+1,606% +$731K ﹤0.01% 1938
2025
Q4 		$53.2K Sell
2,272
-26
-1% -$564 ﹤0.01% 2296
2025
Q3 		$45.8K Sell
2,298
-464
-17% -$8.33K ﹤0.01% 2302
2025
Q2 		$37.8K Hold
2,762
– – ﹤0.01% 2333
2025
Q1 		$30.5K Sell
2,762
-25,404
-90% -$271K ﹤0.01% 2413
2024
Q4 		$300K Buy
28,166
+246
+0.9% +$2.94K ﹤0.01% 2287
2024
Q3 		$355K Buy
27,920
+25,431
+1,022% +$377K ﹤0.01% 2257
2024
Q2 		$41.8K Sell
2,489
-299
-11% -$4.25K ﹤0.01% 2449
2024
Q1 		$41.8K Sell
2,788
-1,689
-38% -$27.6K ﹤0.01% 2521
2023
Q4 		$67.2K Buy
4,477
+160
+4% +$2.08K ﹤0.01% 2530
2023
Q3 		$60.5K Sell
4,317
-2,191
-34% -$35.2K ﹤0.01% 2657
2023
Q2 		$67.4K Buy
+6,508
New +$71.8K ﹤0.01% 2797
2022
Q2 		– Sell
-29,100
Closed -$253K – 3305
2022
Q1 		$253K Sell
29,100
-3,856
-12% -$30.1K ﹤0.01% 2599
2021
Q4 		$313K Hold
32,956
– – ﹤0.01% 2662
2021
Q3 		$554K Sell
32,956
-13,314
-29% -$211K ﹤0.01% 2437
2021
Q2 		$707K Sell
46,270
-2,518
-5% -$45.5K ﹤0.01% 2435
2021
Q1 		$950K Sell
48,788
-142
-0.3% -$3.02K ﹤0.01% 2172
2020
Q4 		$882K Buy
48,930
+958
+2% +$20.1K ﹤0.01% 2116
2020
Q3 		$925K Buy
47,972
+274
+0.6% +$6.21K ﹤0.01% 1908
2020
Q2 		$1.25M Buy
47,698
+647
+1% +$15.8K ﹤0.01% 1740
2020
Q1 		$839K Buy
47,051
+334
+0.7% +$9.02K ﹤0.01% 1774
2019
Q4 		$1.56M Buy
46,717
+48
+0.1% +$1.31K ﹤0.01% 1712
2019
Q3 		$1.11M Buy
46,669
+348
+0.8% +$11.4K ﹤0.01% 1876
2019
Q2 		$1.67M Buy
46,321
+34,446
+290% +$1.27M ﹤0.01% 1659
2019
Q1 		$439K Buy
11,875
+4,614
+64% +$193K ﹤0.01% 2380
2018
Q4 		$313K Buy
7,261
+550
+8% +$24.7K ﹤0.01% 2561
2018
Q3 		$317K Hold
6,711
– – ﹤0.01% 2685
2018
Q2 		$334K Buy
+6,711
New +$391K ﹤0.01% 2669

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s URGN Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its UroGen Pharma (URGN) stake by 16% in Q2 2026, buying an estimated $168K and bringing the position to 44,949 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

California State Teachers Retirement System (CalSTRS) first reported a position in URGN in Q2 2018 and has held it in 29 quarters since. The position peaked at $1.67M in Q2 2019. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 44,949 shares of UroGen Pharma worth $1.65M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) bought 6,199 UroGen Pharma shares in Q2 2026, an estimated $168K.
  • UroGen Pharma made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1686 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in UroGen Pharma in Q2 2018 and has held it in 29 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s UroGen Pharma position peaked at $1.67M in Q2 2019.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.